BC Week In Review | Jun 15, 2009
Clinical News

Cortoss regulatory update

FDA granted 510(k) clearance for Orthovita's Cortoss bone augmentation material to treat vertebral compression fractures. The injectable, bioactive polymer composite that mimics cortical bone already has CE Mark approval in Europe for vertebral and screw...
BC Week In Review | Mar 27, 2000
Company News

Biomet Inc., Orthovita deal

VITA sold its Biogran dental grafting product line to Biomet's Implant Innovations Inc. business (Palm Beach Gardens, Fla.) for $3.9 million in cash. VITA said it will use the proceeds to develop its Cortoss and...
Items per page:
1 - 2 of 2